Preparation of Tetrandrine Nanocrystals by Microfluidic Method and Its In Vitro and In Vivo Evaluation

被引:2
|
作者
Huang, Jinping [1 ]
Huang, Shuwen [2 ]
Liu, Shengjun [1 ]
Feng, Lizhen [1 ]
Huang, Wenxiu [1 ]
Wang, Yao [1 ]
Huang, Dongyi [1 ]
Huang, Tingting [1 ]
Huang, Xingzhen [1 ,3 ]
机构
[1] Guangxi Med Univ, Pharmaceut Coll, Nanning 530021, Peoples R China
[2] Guangxi Med Univ, Affiliated Hosp 1, Nanning 530021, Peoples R China
[3] Guangxi Med Univ, Guangxi Key Lab Bioact Mol Res & Evaluat, Nanning 530021, Peoples R China
关键词
glycyrrhetinic acid; hepatocellular carcinoma; microfluidics; nanocrystals; tetrandrine; HYBRID PACLITAXEL NANOCRYSTALS; SERUM-ALBUMIN NANOPARTICLES; TISSUE DISTRIBUTION; LIVER; GLYCYRRHIZIN; PROGRESS; DELIVERY; PHARMACOKINETICS; OPTIMIZATION; TRANSPORT;
D O I
10.1208/s12249-023-02718-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The anti-hepatocellular carcinoma effects of TET are acknowledged, but its application is hindered by its poor water solubility and low bioavailability. Conventional methods for nanocrystal preparation are laborious and lack control. To address these limitations, we propose employing the microfluidic method in the preparation of TET nanocrystals, aiming to enhance the aforementioned constraints. The objectives of this study were to prepare TET nanocrystals (TET-NC@GL) using a Y-microfluidic method with glycyrrhetinic acid (GL) as a stabilizer. The optimal preparation prescription was determined through a single-factor test and Box-Behnken response surface method. Additionally, the nanocrystals prepared with the commonly used stabilizer polyvinylpyrrolidone K30 (PVPK30), known as TET-NC@PVPK30, were characterized and evaluated for their toxicity to HepG2 cells. Hybridized nanocrystals (TET-HNC@GL and TET-HNC@PVPK30) were synthesized using a water-soluble aggregation-induced emission (AIE) fluorescent probe (TVP). Qualitative and quantitative cellular uptake experiments were conducted using these hybridized nanocrystals. Conducting in vivo pharmacokinetic assays evaluates the relative bioavailability of nanocrystals. The results indicated that TET-NC@GL, optimized using the response surface method, had a particle size of 136.47 +/- 3.31 nm and a PDI of 0.219 +/- 0.002. The administration of TET-NC@GL significantly enhanced the cell inhibition rate compared to the TET group and the TET-NC@PVPK30 group (P < 0.01). Moreover, the qualitative and quantitative cellular uptake results revealed a significant enhancement in cellular uptake in the TET-HNC@GL administration group compared to the TET-HNC@PVPK30 group (P < 0.01). In vivo pharmacokinetic results showed that the bioavailability of TET-NC@GL group was 3.5 times higher than that of the TET group. The results demonstrate the successful preparation of TET-NC@GL nanocrystals.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Preparation of Tetrandrine Nanocrystals by Microfluidic Method and Its In Vitro and In Vivo Evaluation
    Jinping Huang
    Shuwen Huang
    Shengjun Liu
    Lizhen Feng
    Wenxiu Huang
    Yao Wang
    Dongyi Huang
    Tingting Huang
    Xingzhen Huang
    AAPS PharmSciTech, 25
  • [2] Nitrendipine Nanocrystals: Its Preparation, Characterization, and In Vitro–In Vivo Evaluation
    Peng Quan
    Dengning Xia
    Hongze Piao
    Hongyu Piao
    Kai Shi
    Yinnong Jia
    Fude Cui
    AAPS PharmSciTech, 2011, 12 : 1136 - 1143
  • [3] Nitrendipine Nanocrystals: Its Preparation, Characterization, and In Vitro-In Vivo Evaluation
    Quan, Peng
    Xia, Dengning
    Piao, Hongze
    Piao, Hongyu
    Shi, Kai
    Jia, Yinnong
    Cui, Fude
    AAPS PHARMSCITECH, 2011, 12 (04): : 1136 - 1143
  • [4] Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals
    Zuo, Baoyan
    Sun, Yinghua
    Li, Hui
    Liu, Xiaohong
    Zhai, Yinglei
    Sun, Jin
    He, Zhonggui
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 455 (1-2) : 267 - 275
  • [5] Enhanced transdermal delivery of meloxicam by nanocrystals: Preparation, in vitro and in vivo evaluation
    Qina Yu
    Xiying Wu
    Quangang Zhu
    Wei Wu
    Zhongjian Chen
    Ye Li
    Yi Lu
    AsianJournalofPharmaceuticalSciences, 2018, 13 (06) : 518 - 526
  • [6] Enhanced transdermal delivery of meloxicam by nanocrystals: Preparation, in vitro and in vivo evaluation
    Yu, Qin
    Wu, Xiying
    Zhu, Quangang
    Wu, Wei
    Chen, Zhongjian
    Li, Ye
    Lu, Yi
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 13 (06) : 518 - 526
  • [7] Evaluation of Paclitaxel Nanocrystals In Vitro and In Vivo
    Li, Wanqing
    Li, Zhiguo
    Wei, Lisha
    Zheng, Aiping
    DRUG RESEARCH, 2018, 68 (04) : 205 - 212
  • [8] Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo
    Liu, Xingyan
    Liu, Hong
    Liu, Jianqiang
    He, Zhiwei
    Ding, Congcong
    Huang, Guoliang
    Zhou, Weihua
    Zhou, Leshan
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2011, 6 : 241 - 247
  • [9] Preparation, in vitro and in vivo evaluation of bexarotene nanocrystals with surface modification by folate-chitosan conjugates
    Li, Li
    Liu, Yu
    Wang, Jinjing
    Chen, Lijiang
    Zhang, Wenjun
    Yan, Xichen
    DRUG DELIVERY, 2016, 23 (01) : 79 - 87
  • [10] Evaluation of Tetrandrine Sustained Release Calcium Alginate Gel Beads In Vitro and In Vivo
    Ma, Yan
    Li, Wei-Zhong
    Guan, Shi-Xia
    Lai, Xiao-Ping
    Chen, Da-Wei
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2009, 129 (07): : 851 - 854